Industry hires and promotions: January 2017

Patrick Barry, SVP of U.S. branded pharmaceuticals at Endo Pharmaceuticals.

1. Endo Pharmaceuticals hired Patrick Barry as SVP of U.S. branded pharmaceuticals. Barry was most recently GM and head of general medicines and established products North America at Sanofi, where he started as a regional business director in 2000. Barry is leading commercial activities for U.S. branded pharmaceuticals, including strategy, new product planning, marketing, and sales, according to a news release. He replaces Joseph Ciaffoni, who left Endo after a restructuring.  

2. Valeant Pharmaceuticals International hired William Humphries as EVP of dermatology. Humphries previously served as CEO of North America at Merz Pharma, and he has held senior roles at GlaxoSmithKline and Allergan. He reports to Valeant chairman and CEO Joseph Papa. At the same time, Valeant said that Anne Whitaker, EVP and company group chairman, has decided to leave the drugmaker.

See also: Gilead's Meyers on making deals and finding unmet patient needs

3. Tonic Life Communications promoted Stephanie DeViteri to MD of the agency's Philadelphia office. She is responsible for managing operations in the agency's Philadelphia headquarters, including overseeing about 40 staffers, driving business growth, and attracting clients. DeViteri reports to global CEO Maryellen Royle.

4. The Female Health Company / Veru Healthcare appointed Brian Groch as chief commercial officer. He is responsible for organizing all of the company's sales and marketing activities, as well as developing and managing the overall product infrastructure, which includes reimbursement, market access, inventory, and distribution. Groch most recently served as chief commercial officer at Telesta Therapeutics, and he has has held senior sales and marketing roles at Horizon Pharma, Novartis, and Merck.


Opinion

How to Shatter the Glass Ceiling

How Pharma Can Benefit from the Transformation of Pharmacy

Newsletters

Live at MM&M Transforming Healthcare

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Value-based care requires innovators to challenge the status quo

Execs stressed the importance of collaboration, consumer-mindedness.

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.